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Introduction
The combined drugs contain in a single preparation two or more agents with
different therapeutic action, in a fixed dose. These drugs are involved in several
mechanisms which arise in triggering of the pathological condition and increase the
likelihood of obtaining amplified therapeutic response.
Purpose: Evaluation of the domestic pharmaceutical market of fixed doses
combinations of drugs.
Material and methods
Analysis of the State Nomenclature of medicines regarding the products authorized
in the Republic of Moldova on 30.04.2020.
Results
In the last 3 years, the number of drugs registered in the RM is decreased of 1.82%.
About 10% of the total number is combined products (616 out of 6133).
According to the ATC classification, most combinations are in the group “Nervous
system” (18%) and “Respiratory system” (17%), and the fewest are in the class
“Systemic hormonal preparations” (2%). Of the total number of combined drugs, the
remedies used in ear diseases hold a very small percentage, about 0.16%, half of
which are analgesic, anesthetic and anti-inflammatory remedies, the rest being anti-
infective drugs. Out of the total number of otological drugs, only 7 are combined.
Conclusions
There is a low number of combined drugs registered in the RM compared to neighboring states, being opportune the
researches for the development of new domestic combined products.Keywords: combined drugs, Nomenclature of medicines, pharmaceutical market
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THE NUMBER OF COMBINED DRUGS CLASSIFIED ACCORDING TO ATC SYSTEM.
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Nr. d/o ATC Cod The country The manufacturing 
company
Drug names Compoziția medicamentului
I S02DA30 Romany Rompharm Company SRL, Dropleks Fenazone+ Lidocaine
II S02DA30 Ucraine "Zdorovie" SRL Oticain-Zdorovie Fenazone+ Lidocaine
III S02D Germaniy ICN Polfa Rzeszow SA, 
Polonia
Otinum® Choline Salycilate
IV S02DA30 Romany Rompharm Company Otirelax Fenazone+ Lidocaine
V S02AA30 Italy Zambon Anauran Polimexine B+ Neomicine+ Lidocaine
VI S02DA30 France Biocodex Otipax Fenazone+Lidocaine
VII S02DA30 Republic of 
Moldova
SC Flumed-Farm SRL Oti-Calm Lidocaine+Fenazone
VIII S03AA Ucraine Darnița SAP Oftamirin Miramistine
IX S03AA07 Romany Rompharm Company Ciprofloxacin Ciprofloxacine
X S03CA01 Armenia Liqvor SAÎ Floxadex Ciprofloxacine+Dexamethazone
Table 1. Ear drops registered on the pharmaceutical market of the Republic of Moldova
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